In situ expression and serum levels of tumor necrosis factor-α receptors in patients with early stages of systemic sclerosis

Journal of Rheumatology

Volumn 24, Issue 10, 1997, Pages 1936-1943

  Gruschwitz, Matthias S ^a   Albrecht, Monika ^c   Vieth, Gisela ^c   Haustein, Uwe Fritjof ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c NONE

Author keywords

Receptor; Scleroderma; Soluble TNF R; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC SCLEROSIS;

ADULT; AGED; BIOPSY; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SCLERODERMA, SYSTEMIC; SKIN DISEASES;

EID: 0030847892     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Krieg T, Meurer M: Systemic scleroderma. J Am Acad Dermatol 1988;18:457-81.
2. Scharffetter K, Lankat-Buttgereit B, Krieg T: Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization. Eur J Clin Invest 1988;18:9-17.
3. Gruschwitz M, Sepp N, Kofler H, Wick G: Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis. Immunobiology 1991;182:234-55.
4. Gruschwitz M, Von den Driesch P, Kellner I, Hornstein OP, Sterry W: Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis. J Am Acad Dermatol 1992;21:169-77.
5. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T: Co-localization of transforming growth factor B2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 1990;86:917-22.
6. Freundlich B, Bomalski JS, Neilson E, Jimenez SA: Regulation of fibroblast proliferation and collagen synthesis by cytokines. Immunol Today 1986;7:303-7.
7. Kovacs EJ: Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol Today 1991;12:17-23.
8. Springer TA: Adhesion receptors of the immune system. Nature 1990;346:425-34.
9. Bevilacqua MP: Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.
10. Cavallo MG, Pozzilli P, Thorpe R: Cytokines and autoimmunity. Clin Exp Immunol 1994;96:1-7.
11. Zheng RQ, Abney ER, Chu CQ, et al: Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohistochemical methods. Clin Exp Immunol 1991;83:314-9.
12. Buchan G, Barrett K, Fujita T, Taniguchi T, Maini R, Feldmann M: Detection of activated T-cell products in the rheumatoid joint using cDNA probes to IL-2 receptor and IFN gamma. Clin Exp Immunol 1988;71:295-301.
13. Bruns M, Herrmann K, Haustein U-F: Immunological parameters in systemic sclerosis. Int J Dermatol 1996;33:25-32.
14. Haustein U-F, Herrmann K: Environmental scleroderma. Clin Dermatol 1996;12:467-73.
15. Wick G: The multifactoral pathogenesis of autoimmune disease. Immunol Lett 1987;16:249-59.
16. Gruschwitz MS: Expression of TNF-α, PDGF and bFGF in early scleroderma skin lesions, cultured skin fibroblasts and on PBMC (abstr). J Invest Dermatol 1994;102:633A.
17. Gruschwitz MS, Vieth G: Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage. Arthritis Rheum 1997;40:540-50.
18. "Arbeitsgruppe Sklerodermie" der Arbeitsgemeinschaft Dermatologische Forschung (ADF): Klinik der progressiven systemischen Sklerodermie [Clinics of systemic sclerosis.]. Hautarzt 1986;37:320-4.
19. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
20. Kahaleh MB, Sultany GL, Smith EA, et al: A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986;4:969-72.
21. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-29.
22. Schauenstein K, Wick G, Kink H: The micro-membrane-fluorescence test: A new semiautomated technique based on the microtiter system. J Immunol Methods 1976;10:143-50.
23. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach DA: Tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989;264:11974-80.
24. Seckinger P, Isaaz S, Dayer JM: Purification and characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem 1989;264:11966-73.
25. Heilig B, Fiehn C, Brockhaus M. Gallati H, Pezzutto A, Hunstein W: Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol 1993;13:321-8.
26. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA: Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;84:9238-42.
27. Osborn L, Hesslon C, Tizard R, et al: Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59:1203-11.
28. Pober JS, Gimbrone MA, Lapierre LA, et al: Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986;137:1893-6.
29. Gruschwitz MS, Hornstein OP, Von den Driesch P: Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 1995;38:184-9.
30. Mauviel A, Daireaux M, Rédini F, Galera P, Loyau G, Pujol J-P: Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts. FEBS Lett 1988;236:47-52.
31. Solis-Herruzo JA, Brenner DA, Chojkier M: Tumor necrosis factor . α inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J Biol Chem 1988;263:5841-5.
32. Kähäri V-M, Chen YQ, Su MW, Ramierz F, Uitto J: Tumor necrosis factor-α and interferon-γ suppress the activation of human type I collagen gene expression by transforming growth factor-ß. J Clin Invest 1990;86:1489-95.
33. Westermarck J, Häkkinen L, Fiers W, Kähäri V-M: TNF-R55-specific form of human tumor necrosis factor-α induces collagenase gene expression by human skin fibroblasts. J Invest Dermatol 1995;105:197-202.
34. Kuhweide R, Van Damme J, Ceuppens JL: Tumor necrosis factor-α and interleukin 6 synergistically induce T cell growth. Eur J Immunol 1990;20:1019-25.
35. Scheurich P, Thoma B, Ucer U, Pfizenmaier K: Immunoregulatory activity of recombinant human tumor necrosis factor (TNF-α): Induction of TNF receptors on human T-cells and TNF-α mediated enhancement of T-cell responses. J Immunol 1987;138:1786-90.
36. Fritzler MJ, Kinsella TD, Garbutt E: The CREST syndrome: A distinct serologic entity with anticentromere antibodies. Am J Med 1980;69:520-6.
37. Berman B, Wietzerbin J: Tumor necrosis factor-alpha, interferon-alpha and interferon-gamma receptors on human normal and scleroderma dermal fibroblasts in vitro. J Dermatol Sci 1992;3:82-90.